Impact of concomitant use of proton pump inhibitors and clopidogrel or ticagrelor on clinical outcomes in patients with acute coronary syndrome

about

Impact of concomitant use of proton pump inhibitors and clopidogrel or ticagrelor on clinical outcomes in patients with acute coronary syndrome

Item

http://www.wikidata.org/entity/Q36784692

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Impact of concomitant use of p ...... s with acute coronary syndrome

@en

type

Item

label

Impact of concomitant use of p ...... s with acute coronary syndrome

@en

prefLabel

Impact of concomitant use of p ...... s with acute coronary syndrome

@en

P1476

Impact of concomitant use of p ...... s with acute coronary syndrome

@en

P2093

Albert Ariza-Sole

http://www.w3.org/2001/XMLSchema#string

Christoph Liebetrau

http://www.w3.org/2001/XMLSchema#string

Claudio Moretti

http://www.w3.org/2001/XMLSchema#string

Dimitrios Alexopoulos

http://www.w3.org/2001/XMLSchema#string

Emad Abu-Assi

http://www.w3.org/2001/XMLSchema#string

Fabrizio D'Ascenzo

http://www.w3.org/2001/XMLSchema#string

Iván Nuñez-Gil

http://www.w3.org/2001/XMLSchema#string

Jing-Yao Fan

http://www.w3.org/2001/XMLSchema#string

Jorge Saucedo

http://www.w3.org/2001/XMLSchema#string

Jose P Simao Henriques

http://www.w3.org/2001/XMLSchema#string

P2860

Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin

Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population

Impact of proton pump inhibitor therapy on the efficacy of clopidogrel in the CAPRIE and CREDO trials.

Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevati

Clopidogrel with or without omeprazole in coronary artery disease.

Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome.

Prognosis of concomitant users of clopidogrel and proton-pump inhibitors in a high-risk population for upper gastrointestinal bleeding.

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials.

Cytochrome P450 2C19*2 polymorphism and cardiovascular recurrences in patients taking clopidogrel: a meta-analysis.

P304

209-217

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.11909/J.ISSN.1671-5411.2016.03.007

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27103915

http://www.w3.org/2001/XMLSchema#string

P921

clopidogrel

P932

4826890

http://www.w3.org/2001/XMLSchema#string